fbpx

News & Press


The New York Times Publishes MRF Letter to the Editor

September 27, 2010

The MRF submitted a letter to the editor in response to a recent article in The New York Times, “When Testing a Drug Means Withholding It.”  The article focused on the ethics of standard clinical trial protocols in the context of advan …



MRF Scientific Advisor Examines Indoor Tanning

September 13, 2010

The New England Journal of Medicine recently published an article focused on indoor tanning, written by scientific advisor to the MRF and chair of the department of dermatology at Massachusetts General Hospital, David E. Fisher, M.D., Ph.D.  With …



As Children Head Back to School, Parents are Reminded of Need for Sun Safety and Early Detection

September 13, 2010

Contact: Berna Diehl Jones Public Affairs (202) 591-4045 [email protected], N.J.—As summertime comes to a close, many families have left behind long, hot days at the beach and replaced bathing suits with backpacks and books. However, …



New Treatments for Melanoma and the MRF

August 30, 2010

Although the last time a new drug was approved for metastatic melanoma was over a decade ago, recent advances offer new hope for patients.  Two drugs, ipilimumab and PLX4032 have shown promising results and received significant coverage from the m …



New Advances in Melanoma Therapies Offer Hope for Patients

August 25, 2010

USA TODAY and NBC News report on results from a study highlighting a promising new therapy for metastatic melanoma.  The new research, published in the New England Journal of Medicine, examines the experimental therapy called PLX4032.  The Me …